Success Stories: Thanks to Premium Processing, an Indian Research Scientist in Molecular Biology Gets EB1-A Approval in Just 13 Days
Client’s Testimonial:
“Thank you very much, I am happy with your service.”
On August 30th, 2021, we received another EB-1A (Alien of Extraordinary Ability) approval for a Research Scientist in the Field of Molecular Biology (Approval Notice).
General Field: Molecular Biology
Position at the Time of Case Filing: Research Scientist
Country of Origin: India
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: August 30th, 2021
Processing Time: 13 days (Premium Processing Requested)
Case Summary:
The clear national importance of one of our client’s research has led him to find funding from 2 leading national institutes, namely the American Heart Association and the National Institutes of Health. While these grants are reserved solely for research directed at advancing the national interest, they go beyond that and have an impact globally. This is what we showcased as the forerunner while building a strong EB1-A (Alien of Extraordinary Ability) case based on his history as a Ph.D. scholar in Pharmacology wanting to pursue a career in molecular biology. This is also what some of the experts in the field had to say of his work:
“[Client’s] research in the field of molecular biology contributes to the development of targeted treatment strategies for sepsis, among other conditions, and thus directly contributes to the improved treatment and survivability of one of the world’s most pressing medical emergencies.”
"In his research in the field of molecular biology, [client] investigates the implementation of nanotechnology in the development of novel drug and gene delivery methods and characterizes the role of different molecular mechanisms in inflammation and tumorigenesis. His novel methods directly contribute to the development of advanced cancer treatment strategies, which have implications for the improved survivability of various cancers in the United States.”
At the same time, in his research in the field of molecular biology, he conducts critical studies into the role of a variety of molecular mechanisms in inflammation and sepsis. His research directly enables the development of advanced therapeutic treatments and drug delivery methods, and his continued research is, therefore, crucial to improved public health outcomes around the world.
Detailing his other academic records, we pointed out how he has completed at least 30 reviews to date. His research has also resulted in 16 peer-reviewed journal articles (3 of them first-authored), 3 peer-reviewed conference papers, and 1 book chapter, and these publications have been cited a total of 678 times according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of molecular biology. Given that only the most highly esteemed researchers in the field are invited to evaluate the work of their peers, it is clear that he is seen as very knowledgeable in the field.
All of this put together helped make a very convincing case in front of the adjudicating authorities pushing them to take a favorable decision for our client, who then decided to retain us for filing his NIW and I-485 petitions as well. We are thankful to him for his continued trust in NAILG.